225 related articles for article (PubMed ID: 28666967)
1. Signaling via Smad2 and Smad3 is dispensable for adult murine hematopoietic stem cell function in vivo.
Billing M; Rörby E; Dahl M; Blank U; Andradottír S; Ehinger M; Karlsson S
Exp Hematol; 2017 Nov; 55():34-44.e2. PubMed ID: 28666967
[TBL] [Abstract][Full Text] [Related]
2. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
He W; Dorn DC; Erdjument-Bromage H; Tempst P; Moore MA; Massagué J
Cell; 2006 Jun; 125(5):929-41. PubMed ID: 16751102
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
[TBL] [Abstract][Full Text] [Related]
4. SMAD3 and SMAD4 have a more dominant role than SMAD2 in TGFβ-induced chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
de Kroon LM; Narcisi R; van den Akker GG; Vitters EL; Blaney Davidson EN; van Osch GJ; van der Kraan PM
Sci Rep; 2017 Feb; 7():43164. PubMed ID: 28240243
[TBL] [Abstract][Full Text] [Related]
5. Requirement of a dynein light chain in TGFbeta/Smad3 signaling.
Jin Q; Gao G; Mulder KM
J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352
[TBL] [Abstract][Full Text] [Related]
6. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
[TBL] [Abstract][Full Text] [Related]
7. Smad2 and Smad3 have differential sensitivity in relaying TGFβ signaling and inversely regulate early lineage specification.
Liu L; Liu X; Ren X; Tian Y; Chen Z; Xu X; Du Y; Jiang C; Fang Y; Liu Z; Fan B; Zhang Q; Jin G; Yang X; Zhang X
Sci Rep; 2016 Feb; 6():21602. PubMed ID: 26905010
[TBL] [Abstract][Full Text] [Related]
8. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
9. Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation.
Ju W; Ogawa A; Heyer J; Nierhof D; Yu L; Kucherlapati R; Shafritz DA; Böttinger EP
Mol Cell Biol; 2006 Jan; 26(2):654-67. PubMed ID: 16382155
[TBL] [Abstract][Full Text] [Related]
10. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
[TBL] [Abstract][Full Text] [Related]
11. Increased longevity of hematopoiesis in continuous bone marrow cultures and adipocytogenesis in marrow stromal cells derived from Smad3(-/-) mice.
Epperly MW; Cao S; Goff J; Shields D; Zhou S; Glowacki J; Greenberger JS
Exp Hematol; 2005 Mar; 33(3):353-62. PubMed ID: 15730859
[TBL] [Abstract][Full Text] [Related]
12. Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells.
Dzwonek J; Preobrazhenska O; Cazzola S; Conidi A; Schellens A; van Dinther M; Stubbs A; Klippel A; Huylebroeck D; ten Dijke P; Verschueren K
Mol Cancer Res; 2009 Aug; 7(8):1342-53. PubMed ID: 19671686
[TBL] [Abstract][Full Text] [Related]
13. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Brown KA; Pietenpol JA; Moses HL
J Cell Biochem; 2007 May; 101(1):9-33. PubMed ID: 17340614
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin carboxyl-terminal hydrolase-L5 promotes TGFβ-1 signaling by de-ubiquitinating and stabilizing Smad2/Smad3 in pulmonary fibrosis.
Nan L; Jacko AM; Tan J; Wang D; Zhao J; Kass DJ; Ma H; Zhao Y
Sci Rep; 2016 Sep; 6():33116. PubMed ID: 27604640
[TBL] [Abstract][Full Text] [Related]
15. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.
Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH
Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells.
Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A
J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993
[TBL] [Abstract][Full Text] [Related]
17. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.
Sakaki-Yumoto M; Liu J; Ramalho-Santos M; Yoshida N; Derynck R
J Biol Chem; 2013 Jun; 288(25):18546-60. PubMed ID: 23649632
[TBL] [Abstract][Full Text] [Related]
18. Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate.
Wang W; Song B; Anbarchian T; Shirazyan A; Sadik JE; Lyons KM
PLoS Genet; 2016 Oct; 12(10):e1006352. PubMed ID: 27741240
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of TGFβ-induced Smad2/3 phosphorylation reveals a role for receptor tyrosine kinases in modulating TGFβ signaling.
Nyati S; Schinske K; Ray D; Nyati MK; Ross BD; Rehemtulla A
Clin Cancer Res; 2011 Dec; 17(23):7424-39. PubMed ID: 21948232
[TBL] [Abstract][Full Text] [Related]
20. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.
Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T
J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
